Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma

Volume: 40, Pages: 1795
Published: Sep 1, 2012
Abstract
Introduction: null The combination of FF, a novel inhaled corticosteroid and VI, a long-acting beta 2 null agonist, is under development as a once-daily treatment for asthma and COPD. null null Objectives: null To compare the efficacy of FF/VI with FP/SAL in patients with persistent asthma. null null Methods: null In a randomised, double-blind, double-dummy, parallel-group study, 806 patients received FF/VI (100/25mcg, n=403) or FP/SAL...
Paper Details
Title
Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma
Published Date
Sep 1, 2012
Volume
40
Pages
1795
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.